| Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). | |
| | |
MedLine Citation:
|
PMID: 16697307 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: The Homburg Biventricular Pacing Evaluation (HOBIPACE) is the first randomized controlled study that compares the biventricular (BV) pacing approach with conventional right ventricular (RV) pacing in patients with left ventricular (LV) dysfunction and a standard indication for antibradycardia pacing in the ventricle. BACKGROUND: In patients with LV dysfunction and atrioventricular block, conventional RV pacing may yield a detrimental effect on LV function. METHODS: Thirty patients with standard indication for permanent ventricular pacing and LV dysfunction defined by an LV end-diastolic diameter > or =60 mm and an ejection fraction < or =40% were included. Using a prospective, randomized crossover design, three months of RV pacing were compared with three months of BV pacing with regard to LV function, N-terminal pro-B-type natriuretic peptide (NT-proBNP) serum concentration, exercise capacity, and quality of life. RESULTS: When compared with RV pacing, BV stimulation reduced LV end-diastolic (-9.0%, p = 0.022) and end-systolic volumes (-16.9%, p < 0.001), NT-proBNP level (-31.0%, p < 0.002), and the Minnesota Living with Heart Failure score (-18.9%, p = 0.01). Left ventricular ejection fraction (+22.1%), peak oxygen consumption (+12.0%), oxygen uptake at the ventilatory threshold (+12.5%), and peak circulatory power (+21.0%) were higher (p < 0.0002) with BV pacing. The benefit of BV over RV pacing was similar for patients with (n = 9) and without (n = 21) atrial fibrillation. Right ventricular function was not affected by BV pacing. CONCLUSIONS: In patients with LV dysfunction who need permanent ventricular pacing support, BV stimulation is superior to conventional RV pacing with regard to LV function, quality of life, and maximal as well as submaximal exercise capacity. |
| | |
Authors:
|
Michael Kindermann; Benno Hennen; Jens Jung; Jürgen Geisel; Michael Böhm; Gerd Fröhlig |
Related Documents
:
|
8664537 - New indications for permanent cardiac pacing. 11449587 - Effect of different pacing protocols on the induction of atrial fibrillation in a trans... 7471377 - Strength-interval relations in a chronic canine model of myocardial infarction. implica... 6167957 - A new code for pacemaker operating modes. 21253157 - Emergency cardiac care: an update. 294267 - Coronary haemodynamics and myocardial metabolism during cardiopulmonary bypass. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Randomized Controlled Trial Date: 2006-04-24 |
Journal Detail:
|
Title: Journal of the American College of Cardiology Volume: 47 ISSN: 1558-3597 ISO Abbreviation: J. Am. Coll. Cardiol. Publication Date: 2006 May |
Date Detail:
|
Created Date: 2006-05-15 Completed Date: 2006-05-25 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8301365 Medline TA: J Am Coll Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 1927-37 Citation Subset: AIM; IM |
Affiliation:
|
Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. Michael.Kindermann@t-online.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Arrhythmias, Cardiac / complications, therapy* Atrial Fibrillation / therapy Bradycardia / therapy Cardiac Pacing, Artificial / methods* Cardiovascular Agents / therapeutic use Combined Modality Therapy Cross-Over Studies Exercise Tolerance Female Heart Block / therapy Heart Failure / therapy Humans Male Middle Aged Natriuretic Peptide, Brain / blood Peptide Fragments / blood Prospective Studies Quality of Life Single-Blind Method Stroke Volume Ventricular Dysfunction, Left / complications, therapy* Ventricular Function, Left |
| Chemical | |
Reg. No./Substance:
|
0/Cardiovascular Agents; 0/Peptide Fragments; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain |
| Comments/Corrections | |
Comment In:
|
J Am Coll Cardiol. 2006 May 16;47(10):1946-8
[PMID:
16697309
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk fa...
Next Document: Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular n...